Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,474.00    -20.00 (-0.80%)
Bid:
2,474.00
Ask:
2,478.00
Spread: 4.00 (0.162%)
Market Cap: £7.94b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

26 Apr 2023 07:00

RNS Number : 4284X
Bunzl PLC
26 April 2023
 

 

26 April 2023

BUNZL Q1 TRADING STATEMENT

 

Bunzl plc, the specialist international distribution and services Group, today announces its trading statement for the period since 31 December 2022.

 

Bunzl's diversified business model has delivered resilient growth, with Group revenue in the first quarter up 8.4% at actual exchange rates and 1.2% at constant exchange rates. At constant exchange rates, organic growth of 0.6% was driven by underlying revenue growth of 1.5%, partially offset by a negative trading day impact of 0.9%. Underlying revenue growth benefitted from continued inflation support but was impacted by the expected decline in Covid-19 related sales. Acquisitions contributed further growth of 2.7% at constant exchange rates, whilst the disposal of our UK healthcare business impacted revenue by 2.1%. Adjusted operating margin over the quarter was slightly ahead of expectations.

 

Underlying revenue growth in Continental Europe and UK & Ireland continued to be supported by very strong product cost inflation. Underlying revenue growth in North America, whilst benefitting from continued product cost inflation, was impacted by volume softness in our foodservice sector, some of which is anticipated to be temporary. Rest of the World was impacted by the decline in Covid-19 related sales, including the non-repeat of some larger orders made during the first quarter of last year.

 

While we see continued uncertainty relating to the macroeconomic environment, at constant exchange rates the Group continues to expect revenue in 2023 to be slightly higher than in 2022, driven by both organic growth and announced acquisitions, and partially offset by a small impact from the UK healthcare disposal. We expect Group adjusted operating profit to be resilient, with operating margin slightly higher than historical levels.

 

In April 2023, Bunzl entered into an agreement to acquire Dimasa, a distributor of cleaning and hygiene products in the Andalusia region of Spain. The business generated revenue of EUR 4 million (c.£3 million) in 2022. Since the start of the year, Bunzl has also completed the acquisitions of Arbeitsschutz-Express in Germany and Capital Paper in Canada.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Our performance over the quarter continues to demonstrate the resilience of the Bunzl business model and its strategy. I am also pleased to welcome Dimasa to the Bunzl family. This business is a leading distributor in Southern Spain and strengthens our presence in this region. Our pipeline is active and our balance sheet remains strong, and we see significant opportunities for further acquisition growth to supplement our resilient organic growth."

 

Insight event:

On 29 June 2023, Bunzl will be holding a second insight event for investors, with a focus on our North America Business Area. The virtual event will be hosted by Jim McCool, our CEO of North America. The event will be live from 3pm - 4.15pm BST and will include a Q&A session. Registration details will be made available on our website (www.bunzl.com) ahead of the event.

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Teneo

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUGDSDBDDGXU
Date   Source Headline
15th Mar 20184:27 pmRNSAnnual Financial Report
12th Mar 20184:48 pmRNSDirector/PDMR Shareholding
5th Mar 201811:54 amRNSHolding(s) in Company
2nd Mar 20184:16 pmRNSDirector/PDMR Shareholding
2nd Mar 20183:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20183:23 pmRNSDirector/PDMR Shareholding
1st Mar 201811:06 amRNSTotal Voting Rights
26th Feb 201810:22 amRNSDividend Declaration
26th Feb 20187:00 amRNSFinal Results
23rd Feb 20188:00 amRNSAdditional Listing
22nd Feb 20183:30 pmRNSDirector Declaration
13th Feb 20189:06 amRNSHolding(s) in Company
2nd Feb 20184:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20188:00 amRNSAdditional Listing
1st Feb 20184:12 pmRNSTotal Voting Rights
22nd Jan 20188:00 amRNSAdditional Listing
11th Jan 20187:00 amRNSImpact of US Tax Legislation
11th Jan 20187:00 amRNSAcquisition
9th Jan 20184:47 pmRNSDirector/PDMR Shareholding
3rd Jan 20181:38 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:08 pmRNSTotal Voting Rights
21st Dec 20178:00 amRNSAdditional Listing
18th Dec 20174:00 pmRNSHolding(s) in Company
14th Dec 20177:00 amRNSTrading Statement
13th Dec 20179:11 amRNSHolding(s) in Company
7th Dec 201711:36 amRNSIssue of Debt
1st Dec 20174:12 pmRNSTotal Voting Rights
1st Dec 20177:00 amRNSIssue of Debt
30th Nov 20178:00 amRNSAdditional Listing
23rd Nov 20177:00 amRNSAcquisition
17th Nov 20171:18 pmRNSDirector/PDMR Shareholding
15th Nov 201711:49 amRNSHolding(s) in Company
13th Nov 20173:01 pmRNSDividend Reinvestment Plan Terms and Conditions
1st Nov 20173:05 pmRNSBlock listing Interim Review
1st Nov 20172:57 pmRNSTotal Voting Rights
24th Oct 20177:00 amRNSTrading Statement
12th Oct 201710:45 amRNSDirector/PDMR Shareholding
9th Oct 20175:30 pmRNSDirector/PDMR Shareholding
9th Oct 20175:25 pmRNSDirector/PDMR Shareholding
9th Oct 20175:21 pmRNSDirector/PDMR Shareholding
6th Oct 20174:00 pmRNSDirector/PDMR Shareholding
6th Oct 201712:20 pmRNSDirector/PDMR Shareholding
5th Oct 20173:55 pmRNSHolding(s) in Company
2nd Oct 201711:30 amRNSTotal Voting Rights
29th Sep 20174:15 pmRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSCapital Markets Event
22nd Sep 20173:00 pmRNSDirector/PDMR Shareholding
14th Sep 20179:10 amRNSHolding(s) in Company
6th Sep 20179:07 amRNSHolding(s) in Company
1st Sep 20174:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.